SG Americas Securities’s Enfusion, Inc. ENFN Stock Holding History

SG Americas Securities’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-71,604	Closed	-$798K	–	3732
2025 Q1	$798K	Buy	71,604 +45,675	+176%	+$505K	﹤0.01%	1371
2024 Q4	$267K	Sell	25,929 -68,103	-72%	-$658K	﹤0.01%	1895
2024 Q3	$892K	Buy	+94,032	New	+$811K	﹤0.01%	1169
2023 Q4	–	Sell	-77,393	Closed	-$694K	–	3503
2023 Q3	$694K	Buy	+77,393	New	+$735K	0.01%	1537

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SG Americas Securities's ENFN Position: Q2 2025 in Review

SG Americas Securities sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 71,604 shares — an estimated $798K sold.

SG Americas Securities first reported a position in ENFN in Q3 2023 and held it in 4 quarters. The position peaked at $892K in Q3 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

SG Americas Securities reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
SG Americas Securities sold 71,604 Enfusion, Inc. shares in Q2 2025, an estimated $798K.
SG Americas Securities first reported a position in Enfusion, Inc. in Q3 2023 and held it in 4 quarters.
SG Americas Securities's Enfusion, Inc. position peaked at $892K in Q3 2024.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.